It has been stated that a decrease in PON-1 activity occurs in cases of high oxidative stress states, such as metabolic syndrome, obesity, uncontrolled diabetes, cardiovascular disorders, and fatty liver disease [37,38,39]. The gene discussed is PON1; the disease is cardiovascular disorder.